| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0171-2985(98)80040-5 |
| P698 | PubMed publication ID | 9777419 |
| P2093 | author name string | Tosi M | |
| P2860 | cites work | Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements | Q24558897 |
| The sequence of a cDNA encoding functional murine C1-inhibitor protein | Q28513281 | ||
| Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema | Q33894493 | ||
| What do dysfunctional serpins tell us about molecular mobility and disease? | Q34058884 | ||
| Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements | Q34104715 | ||
| Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function | Q34195958 | ||
| Recombinations between Alu repeat sequences that result in partial deletions within the C1 inhibitor gene | Q34327815 | ||
| Efficient detection of point mutations on color-coded strands of target DNA. | Q35079578 | ||
| A cluster of mutations within a short triplet repeat in the C1 inhibitor gene. | Q35801782 | ||
| C1-inhibitor and its genetic alterations in hereditary angioneurotic edema | Q40829855 | ||
| COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization | Q41370342 | ||
| Altered C1 inhibitor genes in type I hereditary angioedema | Q69033492 | ||
| Contiguous deletion and duplication mutations resulting in type 1 hereditary angioneurotic edema | Q72286532 | ||
| P433 | issue | 2 | |
| P921 | main subject | molecular genetics | Q210506 |
| P304 | page(s) | 358-365 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | Immunobiology | Q15754985 |
| P1476 | title | Molecular genetics of C1 inhibitor | |
| P478 | volume | 199 |
| Q43965627 | A novel type III polyketide synthase encoded by a three-intron gene from Polygonum cuspidatum |
| Q36470474 | Acquired form of angioedema of the head and neck related to a deficiency in c1-inhibitor: a case report with a review of the literature |
| Q35381816 | Amniotic fluid embolism pathophysiology suggests the new diagnostic armamentarium: β-tryptase and complement fractions C3-C4 are the indispensable working tools |
| Q34005008 | An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema |
| Q59215908 | Angioedema |
| Q24684165 | C1 inhibitor deficiency: consensus document |
| Q36839961 | C1-inhibitor deficiencies (hereditary angioedema): where are we with therapies? |
| Q34228505 | Characterization of the third SERK gene in pineapple (Ananas comosus) and analysis of its expression and autophosphorylation activity in vitro |
| Q37394385 | Clinical Immunology Review Series: An approach to the patient with angio-oedema |
| Q34580029 | Current management of hereditary angio-oedema (C'1 esterase inhibitor deficiency). |
| Q31015716 | DX-88 and HAE: a developmental perspective |
| Q52603320 | First Analysis of SERPING1 Gene in Patients with Hereditary Angioedema in Colombia Reveals Two Genotypic Variants in a Highly Symptomatic Individual. |
| Q40463262 | HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. |
| Q28972400 | Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment Strategies |
| Q37383209 | Hereditary Angioedema with Recurrent Abdominal Pain in a Patient with a Novel Mutation |
| Q40484335 | Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond |
| Q33986895 | Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain |
| Q33915553 | Hereditary angioedema with normal C1-inhibitor activity in women |
| Q54657692 | Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohort. |
| Q37531616 | Human Plasma-Derived, Nanofiltered, C1-Inhibitor Concentrate (Cinryze®), a Novel Therapeutic Alternative for the Management of Hereditary Angioedema Resulting from C1-Inhibitor Deficiency |
| Q24816630 | Hypoxia-activated genes from early placenta are elevated in preeclampsia, but not in Intra-Uterine Growth Retardation |
| Q24671677 | Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III |
| Q47316465 | Kallikrein Cleaves C3 and Activates Complement. |
| Q38025607 | Long-term prophylaxis in hereditary angio-oedema: a systematic review. |
| Q48241809 | Mutational spectrum of the SERPING1 gene in Swiss patients with hereditary angioedema. |
| Q81450889 | Paternal mosaicism and hereditary angioedema in a Taiwanese family |
| Q43818715 | Psychometric validation of two patient-reported outcome measures to assess symptom severity and changes in symptoms in hereditary angioedema |
| Q93945604 | Rapid detection by fluorescent multiplex PCR of exon deletions and duplications in the C1 inhibitor gene of hereditary angioedema patients |
| Q36925176 | Recent developments in the treatment of acute abdominal and facial attacks of hereditary angioedema: focus on human C1 esterase inhibitor |
| Q39208245 | Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial. |
| Q38855032 | The Story of Angioedema: from Quincke to Bradykinin |
| Q37853060 | The many faces of the contact pathway and their role in thrombosis |
Search more.